As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.

Overcoming the limitations of the triple plasmid transient transfection method for AAV manufacturing.

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

How connecting the data dots can lead to better development and clinical trals.